bht-3009
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2004 (NCT00103974)
Timeline
Indications
Mechanism of action
- Myelin basic proteinSupplementation
MBP supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bht3009
- bht 3009
- bht-3009
- bht-3009
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00382629 | Phase 2 | Feb 1, 2006 | Bayhill Therapeutics |
| NCT00103974 | Phase 1 | Jul 1, 2004 | Bayhill Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayhill Therapeutics | For profit | 2 | 2 | 2 | 2004 |
1 organizations
Page 1 / 1